1.1
Oral fludarabine is recommended as second line therapy for B-cell chronic lymphocytic leukaemia (CLL) for patients who have either failed, or are intolerant of, first line chemotherapy, and who would otherwise have received combination chemotherapy of either:
-
cyclophosphamide, doxorubicin, vincristine and prednisolone (CHOP)
-
cyclophosphamide, doxorubicin and prednisolone (CAP) or
-
cyclophosphamide, vincristine and prednisolone (CVP)